BVF INC/IL - IMMUNE DESIGN CORP ownership

IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 61 filers reported holding IMMUNE DESIGN CORP in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.7%.

Quarter-by-quarter ownership
BVF INC/IL ownership history of IMMUNE DESIGN CORP
ValueSharesWeighting
Q4 2018$6,741,000
-58.1%
5,185,383
+11.3%
0.88%
-37.6%
Q3 2018$16,071,000
-15.1%
4,658,353
+12.0%
1.41%
-23.6%
Q2 2018$18,921,000
+39.6%
4,158,353
+1.3%
1.85%
+34.4%
Q1 2018$13,550,000
+136.4%
4,106,200
+179.4%
1.37%
+98.8%
Q4 2017$5,732,000
-31.7%
1,469,800
+19.1%
0.69%
-51.6%
Q1 2017$8,391,000
+15.6%
1,233,976
-6.5%
1.43%
-2.2%
Q4 2016$7,261,000
-20.2%
1,320,164
+10.0%
1.46%
-14.9%
Q3 2016$9,096,0001,200,0001.71%
Other shareholders
IMMUNE DESIGN CORP shareholders Q2 2017
NameSharesValueWeighting ↓
COLUMN GROUP L P 3,161,942$65,294,000100.00%
ProQuest Associates IV LLC 1,983,858$40,967,0008.41%
Iguana Healthcare Management, LLC 150,000$3,098,0000.98%
SECTORAL ASSET MANAGEMENT INC 810,390$16,735,0000.70%
Cormorant Asset Management, LP 189,000$3,903,0000.52%
SPHERA FUNDS MANAGEMENT LTD. 140,000$2,891,0000.28%
RS INVESTMENT MANAGEMENT CO LLC 750,402$15,496,0000.13%
Eventide Asset Management 102,904$2,125,0000.12%
Rock Springs Capital Management LP 55,000$1,136,0000.08%
Focused Wealth Management, Inc 3,406$70,0000.04%
View complete list of IMMUNE DESIGN CORP shareholders